Showing 1 - 10 of 3,232
Persistent link: https://www.econbiz.de/10011803440
Persistent link: https://www.econbiz.de/10012515856
Persistent link: https://www.econbiz.de/10012423190
The aging population, the increasing number of lifestyle diseases and the increasing proportion of difficult-to-cure illnesses in the EU demands the use of modern medicine and modern medical technology. Such a situation leads to an increase of funds spent on the health sector. Therefore the...
Persistent link: https://www.econbiz.de/10010390284
This paper discusses the relationship between medical innovations and ageing from a health economics perspective and surveys empirical evidence on medical R&D incentives, R&D costs of pharmaceuticals, and the cost-effectiveness of health innovations. Particular focus is on the endogeneity of...
Persistent link: https://www.econbiz.de/10012653346
Persistent link: https://www.econbiz.de/10012438235
of healthcare. A nationally-representative sample of Americans reported their estimated and ideal distributions of … healthcare (unmet need for prescription medications) and death (gains in life expectancy). Respondents across the demographic and … political spectrum wanted mortality and healthcare to be distributed more evenly among the rich and poor than they estimated …
Persistent link: https://www.econbiz.de/10012243587
Persistent link: https://www.econbiz.de/10012105027
Persistent link: https://www.econbiz.de/10012204716
Persistent link: https://www.econbiz.de/10012806200